Syneos Health Translational Science, Sophia-Antipolis, France, provides a suite of integrated scientific capabilities from molecular characterization to lead candidate selection, to biomarker validation and model-based drug development, supporting sponsor’s drug development.
A team of 80+ scientists with expertise in Biomarkers, Pharmacology, DMPK for General medicine, Oncology, Immuno-Inflammatory conditions works in a 31,500sq Laboratory space, with more than 200 state-of-the-art equipment.